Madrid: News from the Vaccine Front—Bloody Complicated?
This concludes our 3-part series.
6401 RESULTS
Sort By:
This concludes our 3-part series.
This is part 2 of our 3-part series.
This is part 1 of our 3-part series.
Stem cells and RNA interference offer the latest and, to some, the greatest hope for novel therapies to fight neurodegenerative diseases...
This is part 2 of our 3-part series.
This is part 3 of our 3-part series.
Famous as they are for their powerful effects throughout the body, circulating stress hormones such as the glucocorticoid cortisol still pose somewhat of a riddle when it comes to...
This is part 1 of our 3-part series.
A mitochondrial matrix protease, which degrades short targeting sequences left over after protein import, can also...
Designing AD trials well would seem to be challenge enough for clinicians in the Alzheimer disease field. But even once that’s done...
Out-of-control T cells are blamed for the encephalitis that doomed Elan’s Aβ vaccine trial for Alzheimer disease (AD), and so researchers have turned their efforts toward...
The 10th International Conference on Alzheimer’s Disease and Related Disorders, ICAD for short, ended yesterday just outside the palatial capital of Spain...
By the wholly unscientific survey of a roving reporter, the single most convincing and surprising molecular biology story that stuck in the minds of scientists at the 10th ICAD meeting was...
When it works properly, the endoplasmic reticulum (ER) constantly pumps out newly synthesized membrane proteins, perfectly folded and sorted to their proper cellular destination...
With multinational cooperation, researchers have tracked down the cause of tau-negative frontotemporal dementia linked to
No filters selected